TJ Biopharma and JumpCan Pharmaceutical Jointly Announce Acceleration of Eftansomatropin Alfa Localization Strategy
Hangzhou, China and Taizhou, China – December 29, 2025 – TJ Biopharma, a fully-integrated biotechnology company focused on drug discovery, clinical development, manufacturing, and collaborative commercialization of innovative biologics in the fields of autoimmune diseases, oncology, and...
JumpCan Pharmaceutical's New Drugs Selected for the First Batch of the Jiangsu Province Innovative Drug and Device Product Catalogue
Recently, the Industry and Information Technology Department of Jiangsu, in conjunction with the Jiangsu Provincial Department of Science and Technology, the Jiangsu Commission of Health, the Jiangsu Healthcare Security Administration, and the Jiangsu Medical Products Administration, released...
Fighting the Flu with a Single Dose — JumpCan's Innovative Anti-Influenza Drug Jikeshu Shines at the VAS Forum
From November 26 to 27, the "China Drugstore Business College VAS Forum" was grandly held in Guangdong Province. Co-organized by the Chain Pharmacy and Clinic Professional Committee of the All-China Federation of Industry and Commerce Medical & Pharmaceutical Industry Chamber, China...
The Class 1 Innovative Anti-influenza Drug, Jikeshu (Sebaloxavir Marboxil Tablets), was Launched on JD Health for the First Time
On October 13th, the innovative Class 1 anti-influenza drug Jikeshu (Sebaloxavir Marboxil Tablets), which only requires one dose of medication for the entire course of treatment, was launched online on the JD Health platform. JumpCan Pharmaceutical relies on JD Health's advantage of...
Three Products of JumpCan Pharmaceutical Honored as "China Drugstore Selected Brands"
From September 25th to 28th, the 2025 China Drugstore All Partners Show was grandly held. During the conference, several authoritative industry honor lists were announced, garnering widespread attention. JumpCan Pharmaceutical's Pudilan Xiaoyan Oral Liquid, Xiao'er Chiqiao Qingre Granules...
Pudilan Xiaoyan Oral Liquid and Pudilan Children's Toothpaste Included in "Expert Consensus on Management of Mucosal Injury Repair in Children"
Recently, the "Expert Consensus on Management of Mucosal Injury Repair in Children" (hereinafter referred to as the "Consensus"), led by the Committee on Pediatric Allergy of the China Maternal and Child Health Association and developed by nearly 20 experts in dermatology, allergology, and...
Two Stars Shine: JumpCan Pharmaceutical's Pudilan and Tonpei Listed on "2025 Healthy China · Brand List"
From August 17 to 20, the 18th Health Industry Ecological Platform (CPEO Summit) was grandly held in Boao, Hainan, where authoritative brand awards of great industry interest were announced. JumpCan Pharmaceutical's exclusive formulation product Pudilan Xiaoyan Oral Liquid and exclusive...
One-Dose Full-Course: Anti-Influenza Class 1 Innovative Drug Jikeshu Approved for Market Launch
On July 18, the Class 1 innovative drug Jikeshu (generic name: Maxiluoshavir Tablets) was officially approved for marketing by the National Medical Products Administration (NMPA). It is indicated for the treatment of uncomplicated influenza A and B in otherwise healthy adults. Jikeshu is a new-generation...
JumpCan Pharmaceutical Expands Digestive Portfolio with New Product Approval! Compound Polyethylene Glycol (3350) Electrolyte Powder Approved
Recently, JumpCan Pharmaceutical received the Drug Registration Certificates issued by the National Medical Products Administration (NMPA) for Compound Polyethylene Glycol (3350) Electrolyte Powder in two specifications (6.9g/bag and 13.9g/bag). This new addition further enriches the...
JumpCan Pharmaceutical's Class 1.1 Innovative TCM Drug Xiao'er Biantong Granules Has Marketing Application Accepted
Recently, JumpCan Pharmaceutical received the "Acceptance Notice" from the National Medical Products Administration (NMPA) for the marketing application of its Class 1.1 innovative traditional Chinese medicine (TCM) drug Xiao'er Biantong Granules. Derived from a renowned physician's proven...